Detalhe da pesquisa
1.
Establishment of primary prostate epithelial and tumorigenic cell lines using a non-viral immortalization approach.
Biol Res
; 57(1): 21, 2024 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38704600
2.
Sunitinib for metastatic renal cell carcinoma: Real world data from the STAR-TOR registry and detailed literature review.
Urol Int
; 2024 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38310863
3.
A Prognostic Risk Score for Prostate Cancer Based on PSMA PET-derived Organ-specific Tumor Volumes.
Radiology
; 307(4): e222010, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37070991
4.
The impact of the extent of the bone involvement on overall survival and toxicity in mCRPC patients receiving [177Lu]Lu-PSMA-617: a WARMTH multicentre study.
Eur J Nucl Med Mol Imaging
; 48(12): 4067-4076, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34031719
5.
Prior therapies as prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients treated with [177Lu]Lu-PSMA-617. A WARMTH multicenter study (the 617 trial).
Eur J Nucl Med Mol Imaging
; 48(1): 113-122, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32383093
6.
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial.
Lancet Oncol
; 21(12): 1574-1588, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32971005
7.
Radioligand therapy using [177Lu]Lu-PSMA-617 in mCRPC: a pre-VISION single-center analysis.
Eur J Nucl Med Mol Imaging
; 47(9): 2106-2112, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32062682
8.
Using Data from a Sickness Fund Claims Database to Assess the Treatment Patterns and Healthcare Resource Utilization among Patients with Metastatic Renal Cell Carcinoma in Germany.
Urol Int
; 104(11-12): 982-993, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32992324
9.
Diagnostic performance of 18F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer.
Eur J Nucl Med Mol Imaging
; 45(12): 2055-2061, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30027419
10.
18F-PSMA-1007 PET/CT at 60 and 120 minutes in patients with prostate cancer: biodistribution, tumour detection and activity kinetics.
Eur J Nucl Med Mol Imaging
; 45(8): 1329-1334, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29541812
11.
Targeting PSMA by radioligands in non-prostate disease-current status and future perspectives.
Eur J Nucl Med Mol Imaging
; 45(5): 860-877, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29335762
12.
Performance comparison of two androgen receptor splice variant 7 (AR-V7) detection methods.
BJU Int
; 122(2): 219-226, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29359890
13.
177Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer.
Eur J Nucl Med Mol Imaging
; 44(10): 1663-1670, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28624848
14.
Second-Line Treatment of Advanced Urothelial Cancer with Paclitaxel and Everolimus in a German Phase II Trial (AUO Trial AB 35/09).
Oncology
; 89(2): 70-8, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25765871
15.
Prostate cancers detected on repeat prostate biopsies show spatial distributions that differ from those detected on the initial biopsies.
BJU Int
; 116(1): 57-64, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24552505
16.
[Emergencies in cancer immunotherapy]. / Notfälle in der Medikamentösen Tumortherapie.
Aktuelle Urol
; 55(1): 28-37, 2024 Feb.
Artigo
em Alemão
| MEDLINE | ID: mdl-37607581
17.
Safety and Efficacy of Extended Therapy with [177Lu]Lu-PSMA: A German Multicenter Study.
J Nucl Med
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38697669
18.
Deep and Durable Prostate-specific Antigen Response to Darolutamide with Androgen Deprivation Therapy and Docetaxel, and Association with Clinical Outcomes for Patients with High- or Low-volume Metastatic Hormone-sensitive Prostate Cancer: Analyses of the Randomized Phase 3 ARASENS Study.
Eur Urol
; 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38644146
19.
Comparative assessment of urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion with the serum [-2]proprostate-specific antigen-based prostate health index for detection of prostate cancer.
Clin Chem
; 59(1): 280-8, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23213079
20.
Advantage of 18F-PSMA-1007 over 68Ga-PSMA-11 PET imaging for differentiation of local recurrence vs. urinary tracer excretion.
Eur J Nucl Med Mol Imaging
; 45(6): 1076-1077, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29445927